Page last updated: 2024-11-03

propafenone and Hypertension

propafenone has been researched along with Hypertension in 11 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to compare the effect of valsartan/amlodipine and atenolol/amlodipine combination in preventing the recurrence of atrial fibrillation (AF) in hypertensive diabetic patients with a history of recent paroxysmal atrial fibrillation."9.13Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. ( Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A, 2008)
"To compare placebo vs two different regimens of propafenone administration--intravenous administration or short-term oral loading--in converting recent-onset atrial fibrillation to sinus rhythm."9.08Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. ( Boriani, G; Capucci, A; Lenzi, T; Magnani, B; Sanguinetti, M, 1995)
"The effectiveness of oral propafenone in converting recent-onset atrial fibrillation to sinus rhythm has been established by controlled trials."9.08Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. ( Biffi, M; Boriani, G; Botto, GL; Broffoni, T; Capucci, A; Della Casa, S; Magnani, B; Rubino, I; Sanguinetti, M, 1997)
"The aim of this study was to compare the effect of valsartan/amlodipine and atenolol/amlodipine combination in preventing the recurrence of atrial fibrillation (AF) in hypertensive diabetic patients with a history of recent paroxysmal atrial fibrillation."5.13Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. ( Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A, 2008)
"To compare placebo vs two different regimens of propafenone administration--intravenous administration or short-term oral loading--in converting recent-onset atrial fibrillation to sinus rhythm."5.08Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. ( Boriani, G; Capucci, A; Lenzi, T; Magnani, B; Sanguinetti, M, 1995)
"The effectiveness of oral propafenone in converting recent-onset atrial fibrillation to sinus rhythm has been established by controlled trials."5.08Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. ( Biffi, M; Boriani, G; Botto, GL; Broffoni, T; Capucci, A; Della Casa, S; Magnani, B; Rubino, I; Sanguinetti, M, 1997)
"Amiodarone was the most widely used active compound (82%) and apparently the most effective."1.39[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs]. ( Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X, 2013)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duricova, J1
Perinova, I1
Jurckova, N1
Kacirova, I1
Grundmann, M1
Deftereos, S1
Giannopoulos, G1
Kossyvakis, C1
Efremidis, M1
Panagopoulou, V1
Raisakis, K1
Kaoukis, A1
Karageorgiou, S1
Bouras, G1
Katsivas, A1
Pyrgakis, V1
Stefanadis, C1
Lip, GY1
Fauchier, L1
Freedman, SB1
Van Gelder, I1
Natale, A1
Gianni, C1
Nattel, S1
Potpara, T1
Rienstra, M1
Tse, HF1
Lane, DA1
Akhmedov, VA1
Dolgikh, VT1
Naumov, DV1
Dvornikov, VE1
Alexoudis, A1
Spyridonidou, A1
Viñolas, X1
Freire, F1
Romero-Menor, C1
Alegret, JM1
Incorvaia, C1
Pravettoni, C1
Riario-Sforza, GG1
Fogari, R1
Zoppi, A1
Mugellini, A1
Corradi, L1
Lazzari, P1
Preti, P1
Derosa, G1
Boriani, G2
Capucci, A2
Lenzi, T1
Sanguinetti, M2
Magnani, B2
Biffi, M1
Botto, GL1
Broffoni, T1
Rubino, I1
Della Casa, S1
Alboni, P1
Pirani, R1
Paparella, N1
Candini, GC1
Tomasi, AM1
Masoni, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Dual Shock Versus Single Shock Synchronized External Direct Current Cardioversion for Atrial Fibrillation - A Double-blinded Randomized Trial[NCT03943693]Phase 4100 participants (Actual)Interventional2019-04-01Terminated (stopped due to Poor enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for propafenone and Hypertension

ArticleYear
Atrial fibrillation.
    Nature reviews. Disease primers, 2016, 03-31, Volume: 2

    Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun

2016

Trials

4 trials available for propafenone and Hypertension

ArticleYear
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
    The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Convert

2013
Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:3

    Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Bl

2008
Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration.
    Chest, 1995, Volume: 108, Issue:2

    Topics: Administration, Oral; Adult; Aged; Atrial Fibrillation; Chi-Square Distribution; Electrocardiography

1995
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
    Annals of internal medicine, 1997, Apr-15, Volume: 126, Issue:8

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Diseases; Humans; Hypertens

1997

Other Studies

6 other studies available for propafenone and Hypertension

ArticleYear
Clinically important interaction between metoprolol and propafenone.
    Canadian family physician Medecin de famille canadien, 2013, Volume: 59, Issue:4

    Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Cytochrome P-450 CYP2D6;

2013
[Preventive strategy for atrial fibrillation in arterial hypertension].
    Klinicheskaia meditsina, 2009, Volume: 87, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A

2009
Images in emergency medicine. Reversible QRS complex widening after oral administration of propafenone.
    Emergency medicine journal : EMJ, 2010, Volume: 27, Issue:11

    Topics: Administration, Oral; Aged; Atrial Fibrillation; Diagnosis, Differential; Dizziness; Electrocardiogr

2010
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
    Medicina clinica, 2013, Apr-20, Volume: 140, Issue:8

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabete

2013
Urticaria-angioedema reaction caused by propafenone.
    Allergy, 2006, Volume: 61, Issue:2

    Topics: Angioedema; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Drug Hypersensitivity; Enalapril;

2006
A method for evaluating different modes of action of an antiarrhythmic drug in man. The effects of propafenone on sinus nodal functions.
    International journal of cardiology, 1985, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Autonomic Nervous S

1985